Enzolytics (ENZC) Stock Turns Volatile: What’s The Buzz?

After having already delivered gains of 9% yesterday, Enzolytics Inc (OTCMKTS:ENZC) has managed to jump by 3% this morning. This morning the company announced that it has managed to bag a distribution license for the pharmaceutical entity based out of Europe.

Enzolytics (ENZC) Stock Turns Volatile: What’s The Buzz?

By way of this license, Enzolytics is going to be able to distribute the anti-HIV1 therapeutic ITV 1 in a number of nations. The nations include Egypt, UAE, Nigeria, Philippines, Tunisia, North Sudan, Tanzania, India, Benin and Togo, Kenya, Uganda, Morocco, Libya, Pakistan, Rwanda and Pakistan.

Related:  Volatility Won't Allow Five Prime Therapeutics (FPRX) To Stay Above $20

The unnamed licensing entity owns a pharmaceutical facility in Eastern Europe. As per the agreement that has been signed by Enzolytics, the company is going to get $1 million upfront and on top of that, it is also going to get a 50% stake in the licensing entity. The licensing entity is worth $8 million. In light of this morning’s rally, it might be worthwhile for investors to keep an eye on Enzolytics.

Michael Rowels

Weekend Contributor. Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.